Trial intelligence / Profile preview

Bioequivalence study of pregabalin 150 mg capsules vs Lyrica 150 mg in healthy Thai volunteers under fasting conditions

TCTR20190516003Phase 0Not yet recruiting

Sponsor
Bio-innova
Start
Sep 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 0, randomised, open-label trial of pregabalin (2 arms), sponsored by Bio-innova. Planned start Sep 2019; status: not yet recruiting.

02

Drugs

pregabalin

Beyond the preview

Go deeper on TCTR20190516003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20190516003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call